Maria Vilanova

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Venues

Pharmaceutics

Molecules (Basel, Switzerland)

Cancers

Universitat de Girona

Universitat Autònoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat de Girona

Spain

Full professor of Biochemistry and Molecular Biology :: Biology

Education History

Universitat Autònoma de Barcelona

Spain

PHD :: Biochemistry and Molecular Biology

Publications

Jessica Castro, Marlon Bravo, Meritxell Albertí, Anaís Marsal, María José Alonso-De Gennaro, Oriol Martínez-Ferraté, Carmen Claver, Piet W N M van Leeuwen, Isabel Romero, Antoni Benito, Maria Vilanova
Dinuclear Iron Complexes of Iminopyridine-Based Ligands as Selective Cytotoxins for Tumor Cells and Inhibitors of Cancer Cell Migration. Pharmaceutics 14 (12) (2022)
Jessica Castro, Marlon Bravo, Meritxell Albertí, Anaís Marsal, María José Alonso-De Gennaro, Oriol Martínez-Ferraté, Carmen Claver, Piet W N M van Leeuwen, Isabel Romero, Antoni Benito, Maria Vilanova
Dinuclear Iron Complexes of Iminopyridine-Based Ligands as Selective Cytotoxins for Tumor Cells and Inhibitors of Cancer Cell Migration. Pharmaceutics 14 (12) (2022)
Jessica Castro, Marlon Bravo, Meritxell Albertí, Anaís Marsal, María José Alonso-De Gennaro, Oriol Martínez-Ferraté, Carmen Claver, Piet W N M van Leeuwen, Isabel Romero, Antoni Benito, Maria Vilanova
Dinuclear Iron Complexes of Iminopyridine-Based Ligands as Selective Cytotoxins for Tumor Cells and Inhibitors of Cancer Cell Migration. Pharmaceutics 14 (12) (2022)
Jessica Castro, Marlon Bravo, Meritxell Albertí, Anaís Marsal, María José Alonso-De Gennaro, Oriol Martínez-Ferraté, Carmen Claver, Piet W N M van Leeuwen, Isabel Romero, Antoni Benito, Maria Vilanova
Dinuclear Iron Complexes of Iminopyridine-Based Ligands as Selective Cytotoxins for Tumor Cells and Inhibitors of Cancer Cell Migration. Pharmaceutics 14 (12) (2022)
Jessica Castro, Marc Ribó, Maria Vilanova, Antoni Benito
Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents. Pharmaceutics 13 (1) (2021)
Jessica Castro, Giusy Tornillo, Gerardo Ceada, Beatriz Ramos-Neble, Marlon Bravo, Marc Ribó, Maria Vilanova, Matthew J Smalley, Antoni Benito
A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers 13 (17) (2021)
Glòria García-Galindo, Jessica Castro, Jesús Matés, Marlon Bravo, Marc Ribó, Maria Vilanova, Antoni Benito
The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27KIP1. Molecules (Basel, Switzerland) 26 (5) (2021)
David Roura Padrosa, Jessica Castro, Alejandro Romero-Casañas, Marc Ribó, Maria Vilanova, Antoni Benito
Construction of Highly Stable Cytotoxic Nuclear-Directed Ribonucleases. Molecules (Basel, Switzerland) 23 (12) (2018)

Maria Vilanova.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Vilanova